Back
Accenture PLC 10K Form
Buy
58
ACN
Accenture PLC
Last Price:
327.62
Seasonality Move:
4.85%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-06-25 | 10Q | ACN/Accenture PLC Quarterly |
2020-03-19 | 10Q | ACN/Accenture PLC Quarterly |
2019-12-19 | 10Q | ACN/Accenture PLC Quarterly |
2019-10-29 | 10K | ACN/Accenture PLC Annual |
2019-06-27 | 10Q | ACN/Accenture PLC Quarterly |
2019-03-28 | 10Q | ACN/Accenture PLC Quarterly |
Receive ACN News And Ratings
See the #1 stock for the next 7 days that we like better than ACN
ACN Financial Statistics
Sales & Book Value
Annual Sales: | $61.59B |
---|---|
Cash Flow: | $3.15B |
Price / Cash Flow: | 22.32 |
Annual Sales: | $40.16 |
Price / Book: | 8.16 |
Profitability
EPS (TTM): | 11.22000 |
---|---|
Net Income (TTM): | $7.16B |
Gross Margin: | $19.7B |
Return on Equity: | 30.99% |
Return on Assets: | 15.03% |
Accenture PLC Earnings Forecast
Key Accenture PLC Financial Ratios
- The Gross Profit Margin over the past 22 years for ACN is 31.99%.
- The Selling, General & Administrative Expenses for ACN have been equal to 16.78% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.69% of Operating Income.
- The Net Earning history of ACN is 11.17% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 17 years.
Accenture PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Information Technology Services |
Sector: | Technology |
Current Symbol: | ACN |
CUSIP: | G1151C |
Website: | accenture.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 1.37 |
Quick Ratio: | 1.24 |
Price-to-Earnings
Trailing P/E Ratio: | 30.6 |
---|---|
Forward P/E Ratio: | 24.13 |
ACN Technical Analysis vs Fundamental Analysis
Buy
58
Accenture PLC (ACN)
is a Buy
Is Accenture PLC a Buy or a Sell?
-
Accenture PLC stock is rated a Buy
The current Accenture PLC [ACN] share price is $327.74. The Score for ACN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.